Biotech · Private company
OPKO IP Holdings II, Inc.
Track this companyFree. Adds OPKO IP Holdings II, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CTAP101 30 μg capsulesPhase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- Sugar pill to CTAP101 30 μg capsulesPhase 3 · Chronic Kidney DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyPHASE3 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01704079 · fetched Nov 12, 2026
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyPHASE3 · COMPLETED · started Sep 1, 2012ClinicalTrials.gov NCT01651000 · fetched Nov 12, 2026